PVI
DRIO icon

Pura Vida Investments’s DarioHealth DRIO Stock Holding History

Pura Vida Investments’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,735
Closed -$6.86M – 238
2021
Q1 		$6.86M Buy
+18,735
New +$8.44M 0.2% 101

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.97B AUM 43.46% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Pura Vida Investments's DRIO Position: Q2 2021 in Review

Pura Vida Investments sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 18,735 shares — an estimated $6.86M sold.

Pura Vida Investments first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $6.86M in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

  • Pura Vida Investments reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 18,735 DarioHealth shares in Q2 2021, an estimated $6.86M.
  • Pura Vida Investments first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
  • Pura Vida Investments's DarioHealth position peaked at $6.86M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.